FDA whacks Megafine India plant with warning for faked test data

Tuesday, May 31, 2016

Faking data has won another Indian drugmaker a stern warning from the FDA. This time it is for a Megafine Pharma plant whose products the FDA banned last year for the kind of data integrity shenanigans that inspectors have found repeatedly in Indian drug and API plants, indicating that some companies refuse to change until they get caught.